Key result
Fibroblast-targeted ITGA8 knockdown significantly reduces AF inducibility and duration in preclinical models.
Why the study?
Atrial fibrillation associated with rheumatic valvular disease involves complex cellular remodeling of the atrial myocardium that is not fully understood.
Answers are grounded in this paper and cite their sources.
ITGA8 drives fibroblast-mediated extracellular matrix remodeling in rheumatic valvular atrial fibrillation, and its targeted suppression reduces atrial fibrosis and AF susceptibility in preclinical models.
Atrial fibrillation (AF) associated with rheumatic valvular disease involves complex cellular remodeling of the atrial myocardium. Here, single-nucleus RNA sequencing of left atrial tissues from healthy donors and patients with persistent rheumatic valvular AF identified disease-associated transcriptional changes across major cardiac cell populations. Fibroblasts showed marked heterogeneity, with expansion of an ITGA8-enriched FB-C2-ELN state associated with extracellular matrix remodeling. Functional experiments demonstrated that ITGA8 promotes cardiac fibroblast proliferation, migration, and matrix production. In an ACh/CaCl2-induced rat model, fibroblast-targeted ITGA8 suppression reduced atrial fibrosis and AF susceptibility. These findings define cellular states associated with atrial remodeling and highlight fibroblast ITGA8 signaling as a regulator of fibrosis-related AF progression.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied Rheumatic valvular atrial fibrillation (n=6). ITGA8 suppression (AAV9-col1a2-ITGA8 shRNA) vs. Negative control (AAV9-col1a2-NC) was evaluated on AF inducibility (p=0.0023). Fibroblast-targeted ITGA8 suppression significantly reduced AF inducibility and shortened AF duration in an ACh/CaCl2-induced rat model.
Synapse has enriched 10 related papers. Consider them for comparative context: